Deposition of soluble amyloid-beta onto amyloid templates: with application for the identification of amyloid fibril extension inhibitors. (Q48100619)

8 February 2018

title

Deposition of soluble amyloid-beta onto amyloid templates: with application for the identification of amyloid fibril extension inhibitors. (English)

1 reference

8 February 2018

author name string

Esler WP

1

1 reference

8 February 2018

Stimson ER

2

1 reference

8 February 2018

Mantyh PW

3

1 reference

8 February 2018

Maggio JE

4

1 reference

8 February 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

8 February 2018

published in

Methods in Enzymology

1 reference

8 February 2018

volume

309

1 reference

8 February 2018

page(s)

350-374

1 reference

8 February 2018

Brain amyloid--a physicochemical perspective

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

A beta deposition inhibitor screen using synthetic amyloid.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Aggregation state-dependent binding of beta-amyloid peptide to protein and lipid components of rat cortical homogenates.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Solubilization and characterization of substance P-binding sites from chick brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Selective inhibition of Abeta fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Isolation of paired helical filaments and amyloid fibers from human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Zinc-induced aggregation of human and rat beta-amyloid peptides in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

Reduction of sulfoxides in peptides and proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909025-4

7 January 2021

10.1016/S0076-6879(99)09025-4

Identifiers

DOI

1 reference

8 February 2018

PubMed ID

10507035

1 reference

8 February 2018